216 related articles for article (PubMed ID: 16100112)
1. Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase.
Wei H; Ruthenburg AJ; Bechis SK; Verdine GL
J Biol Chem; 2005 Nov; 280(44):37041-7. PubMed ID: 16100112
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive structural analysis of the ATPase domain of human DNA topoisomerase II beta bound to AMPPNP, ADP, and the bisdioxopiperazine, ICRF193.
Ling EM; Baslé A; Cowell IG; van den Berg B; Blower TR; Austin CA
Structure; 2022 Aug; 30(8):1129-1145.e3. PubMed ID: 35660158
[TBL] [Abstract][Full Text] [Related]
3. Structure of a topoisomerase II-DNA-nucleotide complex reveals a new control mechanism for ATPase activity.
Schmidt BH; Osheroff N; Berger JM
Nat Struct Mol Biol; 2012 Nov; 19(11):1147-54. PubMed ID: 23022727
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis DNA gyrase ATPase domain structures suggest a dissociative mechanism that explains how ATP hydrolysis is coupled to domain motion.
Agrawal A; Roué M; Spitzfaden C; Petrella S; Aubry A; Hann M; Bax B; Mayer C
Biochem J; 2013 Dec; 456(2):263-73. PubMed ID: 24015710
[TBL] [Abstract][Full Text] [Related]
5. ATPase domain of eukaryotic DNA topoisomerase II. Inhibition of ATPase activity by the anti-cancer drug bisdioxopiperazine and ATP/ADP-induced dimerization.
Hu T; Sage H; Hsieh TS
J Biol Chem; 2002 Feb; 277(8):5944-51. PubMed ID: 11850431
[TBL] [Abstract][Full Text] [Related]
6. Probing conformational changes in human DNA topoisomerase IIα by pulsed alkylation mass spectrometry.
Chen YT; Collins TR; Guan Z; Chen VB; Hsieh TS
J Biol Chem; 2012 Jul; 287(30):25660-8. PubMed ID: 22679013
[TBL] [Abstract][Full Text] [Related]
7. Overall Structures of Mycobacterium tuberculosis DNA Gyrase Reveal the Role of a Corynebacteriales GyrB-Specific Insert in ATPase Activity.
Petrella S; Capton E; Raynal B; Giffard C; Thureau A; Bonneté F; Alzari PM; Aubry A; Mayer C
Structure; 2019 Apr; 27(4):579-589.e5. PubMed ID: 30744994
[TBL] [Abstract][Full Text] [Related]
8. Structure and mechanism of DNA topoisomerase II.
Berger JM; Gamblin SJ; Harrison SC; Wang JC
Nature; 1996 Jan; 379(6562):225-32. PubMed ID: 8538787
[TBL] [Abstract][Full Text] [Related]
9. Communication between the ATPase and cleavage/religation domains of human topoisomerase IIalpha.
Bjergbaek L; Kingma P; Nielsen IS; Wang Y; Westergaard O; Osheroff N; Andersen AH
J Biol Chem; 2000 Apr; 275(17):13041-8. PubMed ID: 10777608
[TBL] [Abstract][Full Text] [Related]
10. Locking the DNA gate of DNA gyrase: investigating the effects on DNA cleavage and ATP hydrolysis.
Williams NL; Maxwell A
Biochemistry; 1999 Oct; 38(43):14157-64. PubMed ID: 10571989
[TBL] [Abstract][Full Text] [Related]
11. Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center.
Brino L; Urzhumtsev A; Mousli M; Bronner C; Mitschler A; Oudet P; Moras D
J Biol Chem; 2000 Mar; 275(13):9468-75. PubMed ID: 10734094
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of the DNA-dependent ATPase activity of human DNA topoisomerase IIbeta: mutation of Ser165 in the ATPase domain reduces the ATPase activity and abolishes the in vivo complementation ability.
West KL; Turnbull RM; Willmore E; Lakey JH; Austin CA
Nucleic Acids Res; 2002 Dec; 30(24):5416-24. PubMed ID: 12490710
[TBL] [Abstract][Full Text] [Related]
13. Structural dissection of ATP turnover in the prototypical GHL ATPase TopoVI.
Corbett KD; Berger JM
Structure; 2005 Jun; 13(6):873-82. PubMed ID: 15939019
[TBL] [Abstract][Full Text] [Related]
14. Hindering the strand passage reaction of human topoisomerase IIalpha without disturbing DNA cleavage, ATP hydrolysis, or the operation of the N-terminal clamp.
Oestergaard VH; Giangiacomo L; Bjergbaek L; Knudsen BR; Andersen AH
J Biol Chem; 2004 Jul; 279(27):28093-9. PubMed ID: 15123700
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide exchange from the high-affinity ATP-binding site in SecA is the rate-limiting step in the ATPase cycle of the soluble enzyme and occurs through a specialized conformational state.
Fak JJ; Itkin A; Ciobanu DD; Lin EC; Song XJ; Chou YT; Gierasch LM; Hunt JF
Biochemistry; 2004 Jun; 43(23):7307-27. PubMed ID: 15182175
[TBL] [Abstract][Full Text] [Related]
16. Identification of a residue involved in transition-state stabilization in the ATPase reaction of DNA gyrase.
Smith CV; Maxwell A
Biochemistry; 1998 Jul; 37(27):9658-67. PubMed ID: 9657678
[TBL] [Abstract][Full Text] [Related]
17. Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187.
Classen S; Olland S; Berger JM
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10629-34. PubMed ID: 12963818
[TBL] [Abstract][Full Text] [Related]
18. Coupling between ATP binding and DNA cleavage by DNA topoisomerase II: A unifying kinetic and structural mechanism.
Mueller-Planitz F; Herschlag D
J Biol Chem; 2008 Jun; 283(25):17463-76. PubMed ID: 18403371
[TBL] [Abstract][Full Text] [Related]
19. Catalytic Mechanism of ATP Hydrolysis in the ATPase Domain of Human DNA Topoisomerase IIα.
Ogrizek M; Janežič M; Valjavec K; Perdih A
J Chem Inf Model; 2022 Aug; 62(16):3896-3909. PubMed ID: 35948041
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerases. In one gate, out the other.
Orphanides G; Maxwell A
Curr Biol; 1994 Nov; 4(11):1006-9. PubMed ID: 7874480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
